Mp62-18 Retreatment Rates Associated With Minimally Invasive Surgical Therapy for BPH/Luts: Findings From the Urologic Diseases in America Project

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology IV (MP62)1 May 2024MP62-18 RETREATMENT RATES ASSOCIATED WITH MINIMALLY INVASIVE SURGICAL THERAPY FOR BPH/LUTS: FINDINGS FROM THE UROLOGIC DISEASES IN AMERICA PROJECT Jake Claflin, Ziya Kirkali, John C. Hornberger, Kyle Buika, Lei Sandy Ye, Po-Lun Chou, Can Feng, Xiaofei Lai, Sushant Joshi, John P. Lavelle, and Chad Ellimoottil Jake ClaflinJake Claflin , Ziya KirkaliZiya Kirkali , John C. HornbergerJohn C. Hornberger , Kyle BuikaKyle Buika , Lei Sandy YeLei Sandy Ye , Po-Lun ChouPo-Lun Chou , Can FengCan Feng , Xiaofei LaiXiaofei Lai , Sushant JoshiSushant Joshi , John P. LavelleJohn P. Lavelle , and Chad EllimoottilChad Ellimoottil View All Author Informationhttps://doi.org/10.1097/01.JU.0001008904.63948.3b.18AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: The landscape of surgical management of men with BPH/LUTS has changed over the last decade. The purpose of this study is to outline national trends in the use of Minimally Invasive Surgical Therapy (MIST) for BPH/LUTS and associated retreatment rates. METHODS: Using national Medicare fee-for-service data from 2012-2021, we identified men aged 65 years and older who received a claim-based diagnosis of BPH and associated lower urinary tract symptoms in 2015, without having a claim-based diagnosis in the 3 years prior (i.e., incident BPH/LUTS). Men in this incident cohort were tracked for 4 years to assess the proportion undergoing transurethral surgery or MIST and the percentage experiencing retreatment within 2 years following their initial BPH/LUTS surgery. Men with retreatment within 30 days were excluded from the analysis. RESULTS: In 2015, there were 317,155 newly recorded cases of BPH/LUTS among men. Out of these individuals, 19,410 (6%) underwent surgery for BPH/LUTS within four years of their diagnosis. Among this group, 14,768 (76%) underwent transurethral surgery, while 4,642 (24%) had MIST. Overall, 1,154 (6%) men required retreatment within two years following their initial surgery, including 596 (4%) of the men who had transurethral surgery and 558 (12%) of those who had MIST. The retreatment rates for transurethral surgery ranged from 3% to 4%, whereas for MIST, they varied from 9% to 16% (Figure 1). CONCLUSIONS: In this cohort of Medicare patients, those who underwent MIST for BPH/LUTS exhibited higher rates of retreatment compared to transurethral surgeries. Enhancing the durability of MIST should be an important clinical and research priority. Download PPT Source of Funding: Contract Number: GS10F0133S 75N94021F00197 © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e1028 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Jake Claflin More articles by this author Ziya Kirkali More articles by this author John C. Hornberger More articles by this author Kyle Buika More articles by this author Lei Sandy Ye More articles by this author Po-Lun Chou More articles by this author Can Feng More articles by this author Xiaofei Lai More articles by this author Sushant Joshi More articles by this author John P. Lavelle More articles by this author Chad Ellimoottil More articles by this author Expand All Advertisement PDF downloadLoading ...